Skip to content

Clinical study on pregnancy outcome of HIFU combined with GnRH-a and GnRH-a alone in the treatment of adenomyosis with fertility requirements

Clinical study on pregnancy outcome of HIFU combined with GnRH-a and GnRH-a alone in the treatment of adenomyosis with fertility requirements

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100042536
Enrollment
Unknown
Registered
2021-01-23
Start date
2021-01-25
Completion date
Unknown
Last updated
2021-05-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Adenomyosis

Interventions

HIFU combined with GnRH-a Group:HIFU combined with GnRH-a Treatment
GnRH-a Group:GnRH-a treat alone

Sponsors

Xiangya Third Hospital of Central South University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
20 Years to 45 Years

Inclusion criteria

Inclusion criteria: 1. Patients with clear diagnosis of adenomyosis have treatment indications and fertility requirements (1) The uterus was enlarged and the thickness of myometrium was more than 3 cm (no more than the size of uterus in 3-month pregnancy); (2) Menorrhagia; (3) They have dysmenorrhea and compression symptoms; 2. Patients without contraindication of sedation and analgesia; 3. Patients with adenomyosis who have not received other treatment within one year, such as laparoscopy, laparotomy, vaginal surgery, radiofrequency, interventional therapy, etc; There was no GnRH-a treatment within half a year before treatment; 4. Patients with complete preoperative examination; 5. Obtain the consent of patients and their families; 6. Subjects with normal ovarian function.

Exclusion criteria

Exclusion criteria: 1. In patients with a history of lower abdominal surgery and abdominal scar width greater than or equal to 1cm, the acoustic channel was abnormal; The positioning is not successful; 2. Patients with acute inflammation of genital tract; 3. Patients with other gynecological malignant diseases, cervical or endometrial precancerous lesions or canceration, ovarian tumors; 4. Subjects with uterine body larger than 3 months of gestation; 5. Subjects with language communication disorder can not cooperate with sedation and analgesia program; 6. Subjects with pelvic endometriosis requiring surgical treatment.

Design outcomes

Primary

MeasureTime frame
pregnancy rate;

Secondary

MeasureTime frame
Median gestational time;Spontaneous abortion rate;live birth rate;Remission of dysmenorrhea;Improvement of menstrual;Reduction of adenomyosis;ovarian function;endometrial receptivity;Depression and anxiety score;

Countries

China

Contacts

Public ContactMin Xue

Xiangya Third Hospital of Central South University

xuemin5908@sina.com+86 13687354678

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026